Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 70

Sort by

Sort Order Select

Journal Articles

Installment of Automation and Modernized Culture Methods Updates a Drug-Sensitivity Screening Platform and Paves the Way to Next-Generation of Precision Medicine

Blood (2024) 144 (Supplement 1): 7475.

https://doi.org/10.1182/blood-2024-199921

Published: 2024

Journal Articles

Treatment Outcomes of Adult Patients with B-Cell Acute Lymphoblastic Leukemia Relapsed after Allogeneic Stem Cell Transplant in the Era of Novel Immunochemotherapeutic Agents

Blood (2024) 144 (Supplement 1): 3541.

https://doi.org/10.1182/blood-2024-199077

Published: 2024

Journal Articles

Impact of Conditioning Intensity and Regimen on Outcomes after Unrelated Cord Blood Transplantation for Patients with Myelodysplastic Syndrome

Machiko Fujioka, Hidehiro Itonaga, Yasushi Miyazaki, Yoshimitsu Shimomura, Naoyuki Uchida, Satoshi Takahashi, Makoto Onizuka, Yasunori Ueda, Yasufumi Uehara, Masatsugu Tanaka, Yoshiko Matsuhashi, Shigesaburo Miyakoshi, Haruyuki Tanaka, Toshiro Kawakita, Fumihiko Ishimaru, Junya Kanda, Tatsuo Ichinohe, Yoshiko Atsuta, Ken Ishiyama

Blood (2023) 142 (Supplement 1): 3536.

https://doi.org/10.1182/blood-2023-179157

Published: 2023

Journal Articles

The HLA-B Leader MM Genotype Has a Negative Impact on Outcomes in HLA-B One Antigen Mismatched and HLA-B Matched Cord Blood Transplantation without Anti-Thymocyte Globulin: Analysis of the Japanese Society for Transplantation and Cellular Therapy

Blood (2023) 142 (Supplement 1): 1048.

https://doi.org/10.1182/blood-2023-178905

Published: 2023

Journal Articles

A Novel Scoring System Using Geriatric Nutritional Risk Index, C-Reactive Protein, and Disease Status Predicts Survival after Second Allogeneic Stem Cell Transplantation

Blood (2023) 142 (Supplement 1): 3606.

https://doi.org/10.1182/blood-2023-174312

Published: 2023

Journal Articles

Efficacy of Cord Blood Transplantation for the Management of Chronic Myelomonocytic Leukemia: A Registry-Based Study in Japan

Blood (2023) 142 (Supplement 1): 3577.

https://doi.org/10.1182/blood-2023-173603

Published: 2023

Journal Articles

Comparing Single Cord Blood Transplantation and Matched Related Donor Transplantation in Non-Remission Acute Myeloid Leukemia

Blood (2021) 138 (Supplement 1): 1790.

https://doi.org/10.1182/blood-2021-147645

Published: 2021

Journal Articles

Allogeneic Stem Cell Transplantation Conditioned with Myeloablative Regimens Containing Total Body Irradiation in Adolescent and Young Adult Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia Who Were Treated with Pediatric-Type Chemotherapy

Blood (2021) 138 (Supplement 1): 2283.

https://doi.org/10.1182/blood-2021-151855

Published: 2021

Journal Articles

The Role of Fibrinolytic Factors, a Subset of Angiocrine Factors in Cytokine Storm-Associated Diseases

Koichi Hattori, MD PhD, Hiroshi Shimazu, MD PhD, Satoshi Takahashi, MD PhD, Beate Heissig, MDPhD

Blood (2020) 136 (Supplement 1): 33–34.

https://doi.org/10.1182/blood-2020-134183

Published: 2020

Journal Articles

Prognostic impact of circulating tumor DNA status post–allogeneic hematopoietic stem cell transplantation in AML and MDS

Blood (2019) 133 (25): 2682–2695.

https://doi.org/10.1182/blood-2018-10-880690

Published: 2019

Includes: Supplemental data

Journal Articles

Prognostic Impact of Circulating Tumor DNA Status Post-Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia and Myelodysplastic Syndrome

Sousuke Nakamura, MD, Kazuaki Yokoyama, MD PhD, Eigo Shimizu, Nozomi Yusa, Miho Ogawa, MD, Tomomi Takei, MD, Asako Kobayashi, Mika Ito, Masamichi Isobe, MD PhD, Takaaki Konuma, MD PhD, Seiko Kato, MD PhD, Rika Kasajima, PhD, Yuka Wada, Tokiko Nagamura-Inoue, MDPhD, Rui Yamaguchi, PhD, Satoshi Takahashi, MD PhD, Seiya Imoto, PhD, Satoru Miyano, PhD, Arinobu Tojo, MD PhD

Blood (2018) 132 (Supplement 1): 247.

https://doi.org/10.1182/blood-2018-99-117938

Published: 2018

Journal Articles

Who Is the Best Donor for the Second Transplant?: HLA Discrepancy between Graft and Host Rather Than That Graft and First Donor May Impact the Second Transplant Outcome from the JSHCT

Yoshinobu Maeda, MD PhD, Tomotaka Ugai, MD, Eisei Kondo, Kazuhiro Ikegame, MD PhD, Makoto Murata, MD PhD, Naoyuki Uchida, MD PhD, Toshihiro Miyamoto, MD PhD, Satoshi Takahashi, MD PhD, Kazuteru Ohashi, MD PhD, Hirohisa Nakamae, MD PhD, Makoto Hirokawa, MD PhD, Tatsuo Ichinohe, MD PhD, Yoshiko Atsuta, MD PhD, Yoshinobu Kanda, MD PhD, Junya Kanda, MD

Blood (2018) 132 (Supplement 1): 4635.

https://doi.org/10.1182/blood-2018-99-112796

Published: 2018

Journal Articles

Impact of Homozygous Conserved Extended HLA Haplotypes on Cord Blood Transplantation: Implications for Induced Pluripotent Stem Cell Banking and Transplantation

Yasuo Morishima, MD PhD, Satoko Morishima, MD PhD, Makoto Murata, MD PhD, Nobuyoshi Arima, MD PhD, Naoyuki Uchida, MD PhD, Yuji Ohno, MD PhD, Satoshi Takahashi, MD PhD, Yoshiko Matsuhashi, MD PhD, Makoto Onizuka, MD PhD, Tetsuya Eto, MD PhD, Yoshiko Atsuta, MD PhD, Takahiro Fukuda, MD PhD, Tatsuo Ichinohe, MD PhD, Shunichi Kato, MD PhD, Junya Kanda, MD

Blood (2018) 132 (Supplement 1): 2097.

https://doi.org/10.1182/blood-2018-99-110193

Published: 2018

Journal Articles

Personalized Circulating Tumor DNA Predicts Relapse after Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia and Myelodysplastic Syndrome

Blood (2017) 130 (Supplement 1): 3268.

https://doi.org/10.1182/blood.V130.Suppl_1.3268.3268

Published: 2017

Journal Articles

Patient-Reported Quality of Life after Allogeneic Hematopoietic Cell Transplantation According to Types and Severity of Chronic Gvhd

Saiko Kurosawa, MD, Kumi Oshima, Takuhiro Yamaguchi, Atsumi Yanagisawa, Takahiro Fukuda, Heiwa Kanamori, MD, Takehiko Mori, MD PhD, Satoshi Takahashi, MD PhD, Tadakazu Kondo, MD PhD, Akio Kohno, Aika Seto, MD, Yukari Umemoto, Takanori Teshima, MD PhD, Shuichi Taniguchi, MD PhD, Takuya Yamashita, Yoshiko Atsuta, MD PhD

Blood (2016) 128 (22): 1240.

https://doi.org/10.1182/blood.V128.22.1240.1240

Published: 2016

Journal Articles

Exploratory Introduction of Cognitive Computing to Clinical Sequencing in Hematological Malignancies

Blood (2016) 128 (22): 5262.

https://doi.org/10.1182/blood.V128.22.5262.5262

Published: 2016

Journal Articles

Clinical Profile and BRAF Status of 30 Japanese Patients with Adult Langerhans Cell Histiocytosis

Miho Ogawa, MD, Masayuki Kobayashi, MD, Koji Jimbo, MD, Toyotaka Kawamata, MD PhD, Kazuaki Yokoyama, MD PhD, Nobuhiro Ohno, MD, Yoichi Imai, MD PhD, Satoshi Takahashi, MD PhD, Arinobu Tojo, MD PhD

Blood (2016) 128 (22): 4883.

https://doi.org/10.1182/blood.V128.22.4883.4883

Published: 2016

Journal Articles

Proof of Benefit in Multiple-Cord Blood Transplantation Evidenced By Early Hematopoietic Reconstitution

Takashi Ishida, MD, Satoshi Takahashi, MD,PhD, Chen-Yi Lai, PhD, Masaaki Higashihara, MD, PhD, Hiromitsu Nakauchi, MD PhD, Makoto Otsu, MD, PhD

Blood (2015) 126 (23): 3071.

https://doi.org/10.1182/blood.V126.23.3071.3071

Published: 2015

Journal Articles

Donor Cell-Derived Hematologic Malignancy: A Survey of Complication Working Group of the Japan Society for Hematopoietic Cell Transplantation

Motohiro Kato, MD PhD, Takuya Yamashita, MD PhD, Ritsuro Suzuki, MD PhD, Kimikazu Matsumoto, MD PhD, Hisakazu Nishimori, Satoshi Takahashi, MD, Koji Iwato, MD, Chiaki Nakaseko, MD PhD, Tadakazu Kondo, MD, Kazunori Imada, Fumihiko Kimura, MD, Tatsuo Ichinohe, MDPhD, Yoshiko Hashii, MD PhD, Koji Kato, MD PhD, Yoshiko Atsuta, MDPhD, Shuichi Taniguchi, MD PhD, Takahiro Fukuda, MD

Blood (2015) 126 (23): 859.

https://doi.org/10.1182/blood.V126.23.859.859

Published: 2015

Journal Articles

The Impact of Donor Age on Outcome after Unrelated Bone Marrow Transplantation: Comparison with Unrelated Cord Blood Transplantation

Sachiko Seo, MD PhD, Junya Kanda, Yoshiko Atsuta, MDPhD, Naoyuki Uchida, Kazuteru Ohashi, MD FACP, Takahiro Fukuda, MD, Satoshi Takahashi, MD,PhD, Yukiyasu Ozawa, MD, Makoto Onizuka, MD PhD, Minoko Takanashi, MD PhD, Nobuhiro Tsukada, MD PhD, Shunichi Kato, MD PhD, Fumihiko Kimura, MD, Yoshinobu Kanda, MD PhD, Koichi Miyamura, MD PhD

Blood (2015) 126 (23): 154.

https://doi.org/10.1182/blood.V126.23.154.154

Published: 2015

NARROW

Installment of Automation and Modernized Culture Methods Updates a Drug-Sensitivity Screening Platform and Paves the Way to Next-Generation of Precision Medicine

Treatment Outcomes of Adult Patients with B-Cell Acute Lymphoblastic Leukemia Relapsed after Allogeneic Stem Cell Transplant in the Era of Novel Immunochemotherapeutic Agents

Impact of Conditioning Intensity and Regimen on Outcomes after Unrelated Cord Blood Transplantation for Patients with Myelodysplastic Syndrome

The HLA-B Leader MM Genotype Has a Negative Impact on Outcomes in HLA-B One Antigen Mismatched and HLA-B Matched Cord Blood Transplantation without Anti-Thymocyte Globulin: Analysis of the Japanese Society for Transplantation and Cellular Therapy

A Novel Scoring System Using Geriatric Nutritional Risk Index, C-Reactive Protein, and Disease Status Predicts Survival after Second Allogeneic Stem Cell Transplantation

Efficacy of Cord Blood Transplantation for the Management of Chronic Myelomonocytic Leukemia: A Registry-Based Study in Japan

Comparing Single Cord Blood Transplantation and Matched Related Donor Transplantation in Non-Remission Acute Myeloid Leukemia

Allogeneic Stem Cell Transplantation Conditioned with Myeloablative Regimens Containing Total Body Irradiation in Adolescent and Young Adult Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia Who Were Treated with Pediatric-Type Chemotherapy

The Role of Fibrinolytic Factors, a Subset of Angiocrine Factors in Cytokine Storm-Associated Diseases

Prognostic impact of circulating tumor DNA status post–allogeneic hematopoietic stem cell transplantation in AML and MDS

Prognostic Impact of Circulating Tumor DNA Status Post-Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia and Myelodysplastic Syndrome

Who Is the Best Donor for the Second Transplant?: HLA Discrepancy between Graft and Host Rather Than That Graft and First Donor May Impact the Second Transplant Outcome from the JSHCT

Impact of Homozygous Conserved Extended HLA Haplotypes on Cord Blood Transplantation: Implications for Induced Pluripotent Stem Cell Banking and Transplantation

Personalized Circulating Tumor DNA Predicts Relapse after Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia and Myelodysplastic Syndrome

Patient-Reported Quality of Life after Allogeneic Hematopoietic Cell Transplantation According to Types and Severity of Chronic Gvhd

Exploratory Introduction of Cognitive Computing to Clinical Sequencing in Hematological Malignancies

Clinical Profile and BRAF Status of 30 Japanese Patients with Adult Langerhans Cell Histiocytosis

Proof of Benefit in Multiple-Cord Blood Transplantation Evidenced By Early Hematopoietic Reconstitution

Donor Cell-Derived Hematologic Malignancy: A Survey of Complication Working Group of the Japan Society for Hematopoietic Cell Transplantation

The Impact of Donor Age on Outcome after Unrelated Bone Marrow Transplantation: Comparison with Unrelated Cord Blood Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only